Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
7.71
+0.38 (5.18%)
Mar 6, 2026, 4:00 PM EST
38.42%
Market Cap 4.87B
Revenue (ttm) 267.66M
Net Income (ttm) -220.72M
Shares Out 630.31M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,657,720
Average Volume 9,633,221
Open 7.36
Previous Close 7.33
Day's Range 7.27 - 7.73
52-Week Range 4.49 - 9.20
Beta 0.60
RSI 60.16
Earnings Date Apr 21, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.66 million, an increase of 7.86% compared to the previous year's 248.15 million. Losses were -220.72 million, -31.41% less than in 2024.

Financial Statements

News

There is no news available yet.